Bristol Myers Squibb (NYSE: BMY) reported its second quarter 2025 earnings results today.
Total revenues inched up 1% year-over-year to $12.3 billion.
Net earnings attributable to BMS were $1.31 billion, or $0.64 per share, compared to $1.68 billion, or $0.83 per share, last year. Adjusted EPS decreased 29% to $1.46.
Bristol Myers Squibb expects full-year 2025 revenue to range between $46.5-47.5 billion and adjusted EPS to range between $6.35-6.65.
Wall Street's weekly performance was near the flat line heading into Friday. Things started OK on the final trading day...
BlackRock is seeing a shift among Big Tech investors.Jay Jacobs, the firm's U.S. head of equity ETFs, finds they're going...
Company: Atkore (ATKR)Business: Atkore is a manufacturer of electrical products for construction and renovation markets, and safety and infrastructure products...
Pictured here is Shanghai Port's foreign trade container terminal in Shanghai, China on October 9, 2025.Cfoto | Future Publishing |...
Inside Creative House / Shutterstock.comMore aggressive treatment of high blood pressure may be necessary for those hoping to lower their...
Julia Zavalishina / Shutterstock.comIt’s that special time of year again. No, not the holidays. It’s Medicare’s open enrollment period, from...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
